Travere Therapeutics (TVTX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

TVTX is expected to report earnings to rise 2.49% to -66 cents per share on November 06

Travere Therapeutics TVTX Stock Earnings Reports

Q3'24

Est.

$-0.67

Q2'24

Beat

by $0.14

Q1'24

Beat

by $2.43

Q4'23

Beat

by $2.12

Q3'23

Beat

by $3.33

The last earnings report on August 01 showed earnings per share of -64 cents, beating the estimate of -79 cents. With 7.59M shares outstanding, the current market capitalization sits at 839.88M.

View a ticker or compare two or three

Compare

TVTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TVTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for TVTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3611 Valley Centre Drive

Phone

+1 888 969-7879

Employees

380

Web

https://www.travere.com